ASBP

Aspire Biopharma
ASBP

3 hedge funds and large institutions have $90.4K invested in Aspire Biopharma in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 16 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$940K
2
+$13.6K

Top Sellers

1
-$2.35M
2
-$1.93M
3
-$1.66M
4
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$1.66M
5
EAM
Exos Asset Management
New York
-$1.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$81.7K
2
$8.75K
3
–
4
–
5
–
6
–
7
–
8
–
9
–
10
–
11
–
12
–
13
–
14
–
15
–
16
–
17
–
18
–
19
–
20
–